Stocks
Haemonetics Corporation

Haemonetics CorporationHAE

NYSEHealthcareMedical Devices$102.69+0.72%

Price as of · delayed, not real-time

A global provider of blood management solutions, specializing in devices and software for blood collection, transfusion, and cellular therapy. The company is a key player in the healthcare supply chain, with a focus on improving efficiency and safety in blood-related procedures. Investors monitor its performance due to its role in addressing critical healthcare needs and its recurring revenue model.

Market Cap: $2.8B52W Range: $47.32-$109.57

Congressional Interest in Haemonetics Corporation (HAE)

5 members of Congress have disclosed 22 trades in Haemonetics Corporation (HAE), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
22
Unique Politicians
5
Buys
12
Sells
9

Who in Congress Is Trading HAE?

2021-05-07$1K-$15K
Stock
2021-05-06$1K-$15K
Stock
2021-01-25$1K-$15K
Stock
2020-10-16$1K-$15K
Stock
2020-09-15$1K-$15K
Stock
2020-08-14$1K-$15K
Stock
2020-06-01$1K-$15K
Stock
2020-05-28$1K-$15K
Stock
2020-05-19$1K-$15K
Stock
2020-05-15$1K-$15K
Stock
2018-08-07$1K-$15K
Stock
2018-06-14$1K-$15K
Stock
2018-06-07$1K-$15K
Stock
2012-03-12
Stock
2009-07-01$1K-$15K
Stock
2009-07-01$1K-$15K
Stock
2008-03-10
Stock
2008-03-10
Stock
2007-11-04($14,122.76)
Stock
2007-11-04$14,122.70
Stock
2007-11-04$14,122.76
Stock
2001-07-09$1K-$15K
Stock